NAD metabolism fuels human and mouse intestinal inflammation.
Romana Raphaela GernerVictoria KlepschSophie MacheinerKathrin ArnhardTimon E AdolphChristoph GranderVerena WieserAlexandra PfisterPatrizia MoserNatascha Hermann-KleiterGottfried BaierHerbert OberacherHerbert TilgAlexander R MoschenPublished in: Gut (2017)
Our data emphasise the importance of NAD immunometabolism for mucosal immunity and highlight FK866-mediated NAMPT blockade as a promising therapeutic approach in acute intestinal inflammation.